1. Home
  2. DGLY vs BDRX Comparison

DGLY vs BDRX Comparison

Compare DGLY & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Digital Ally Inc.

DGLY

Digital Ally Inc.

HOLD

Current Price

$1.07

Market Cap

2.5M

Sector

Technology

ML Signal

HOLD

Logo Biodexa Pharmaceuticals plc

BDRX

Biodexa Pharmaceuticals plc

HOLD

Current Price

$4.84

Market Cap

2.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DGLY
BDRX
Founded
2004
2000
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5M
2.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DGLY
BDRX
Price
$1.07
$4.84
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
806.1K
1.7M
Earning Date
12-29-2025
09-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$19,097,965.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$7.38
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.08
$3.58
52 Week High
$1,600.00
$92.00

Technical Indicators

Market Signals
Indicator
DGLY
BDRX
Relative Strength Index (RSI) 35.36 47.49
Support Level $1.27 $4.00
Resistance Level $1.41 $8.94
Average True Range (ATR) 0.13 1.30
MACD -0.00 0.11
Stochastic Oscillator 0.00 23.22

Price Performance

Historical Comparison
DGLY
BDRX

About DGLY Digital Ally Inc.

Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.

About BDRX Biodexa Pharmaceuticals plc

Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.

Share on Social Networks: